DMD - dystrophin Gene

Species: Macaca fascicularis

Gene Type: protein coding
Gene ID: 102141166

DMD Products (10)

mRNA Protein Name
XM_045384002.1 XP_045239937.1 dystrophin isoform X4
XM_045384003.1 XP_045239938.1 dystrophin isoform X6
XM_015443666.2 XP_015299152.2 dystrophin isoform X8
XM_015443667.2 XP_015299153.2 dystrophin isoform X9
XM_015443656.2 XP_015299142.2 dystrophin isoform X3
XM_045384000.1 XP_045239935.1 dystrophin isoform X1
XM_015443657.2 XP_015299143.2 dystrophin isoform X5
XM_015443662.2 XP_015299148.2 dystrophin isoform X7
XM_045384004.1 XP_045239939.1 dystrophin isoform X10
XM_045384001.1 XP_045239936.1 dystrophin isoform X2
Protein Preferred Names Protein Names

dystrophin

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (5)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-14842 Givinostat Inhibitor 98.67% Yes
HY-132611 Golodirsen 96.12% Unkown
HY-132611A Golodirsen sodium Modulator 92.00% Unkown
HY-132584A Casimersen sodium 98.50% Unkown
HY-132584 Casimersen 92.50% Unkown

Clinical Phase

Bioactive Molecules (6)
Cat. No. Product Name Effect
Purity Phase
HY-132586A Viltolarsen sodium Modulator 95.25% Phase 4
HY-132586 Viltolarsen Modulator 95.25% Phase 4
HY-108753 Eteplirsen 98.50% Phase 3
HY-134377 Bocidelpar Modulator 98.08% Phase 2
HY-17614 Ezutromid 98.87% Phase 2
HY-127137 Adenylosuccinic acid 99.74% Phase 1
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99857 Domagrozumab Inhibitor 96.34% Phase 2

Pre-clinical Phase

Bioactive Molecules (20)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-152182 ML-SA5 Agonist 99.69% Unkown
HY-147332 TCL053 99.97% Unkown
HY-15898 Y-320 99.03% Unkown
HY-122631 TG693 99.95% Unkown
HY-101459 RTC13 98.01% Unkown
HY-127137A Adenylosuccinic acid tetraammonium 99.62% Unkown
HY-139972 PROTAC(H-PGDS)-7 99.42% Unkown
HY-114739 MA-0204 Modulator 99.31% Unkown
HY-153369 BAY-747 Activator 98.01% Unkown
HY-122588A Negamycin hydrochloride 80.0% Unkown
HY-150237 FITC-labeled Drisapersen sodium Inhibitor 92.99% Unkown
HY-RS03823 DMD Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-147253 Brogidirsen / Unkown
HY-14931 Naproxcinod Inhibitor / Unkown
HY-150077 Utrophin modulator 1 / Unkown
HY-150078 OX01914 / Unkown
HY-177659 Rimigorsen Inhibitor / Unkown
HY-177659A Rimigorsen sodium Inhibitor / Unkown
HY-RS18019 Dmd Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24492 Dmd Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990051 Delpacibart 98.06% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens DMD NCBI NCBI:1756